Voyager Therapeutics, Inc. (VYGR)

Voyager Therapeutics Revenue

Voyager Therapeutics had revenue of $24.63M in the quarter ending September 30, 2024, with 433.79% growth. This brings the company's revenue in the last twelve months to $163.78M, up 3.40% year-over-year. In the year 2023, Voyager Therapeutics had annual revenue of $250.01M with 511.16% growth.

• Revenue (ttm): $163.78M
• Revenue Growth: +3.40%
• P/S Ratio: 1.95
• Revenue / Employee: $1,011,012
• Employees: 162
• Market Cap: 314.10M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	250.01M	209.10M	511.16%
Dec 31, 2022	40.91M	3.49M	9.33%
Dec 31, 2021	37.42M	-133.71M	-78.14%
Dec 31, 2020	171.13M	66.74M	63.93%
Dec 31, 2019	104.39M	96.77M	1,270.14%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.